0001562180-17-001461.txt : 20170404
0001562180-17-001461.hdr.sgml : 20170404
20170404214117
ACCESSION NUMBER: 0001562180-17-001461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170331
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEFKOFF KYLE
CENTRAL INDEX KEY: 0001191818
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 17740941
MAIL ADDRESS:
STREET 1: 3200 WALNUT ST
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-03-31
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001191818
LEFKOFF KYLE
C/O BOULDER VENTURES
1941 PEARL STREET, SUITE 300
BOULDER
CO
80302
true
false
false
false
Common Stock
2016-11-28
5
G
false
E
2000.00
0.00
D
6585.00
D
Common Stock
2017-03-31
4
M
false
25000.00
3.69
A
31585.00
D
Common Stock
2017-03-31
4
M
false
20000.00
4.36
A
51585.00
D
Common Stock
2017-03-31
4
S
false
45000.00
8.92
D
6585.00
D
Common Stock
45000.00
I
See footnote
Stock Option
3.69
2017-03-31
4
M
false
25000.00
0.00
D
2022-04-25
Common Stock
25000.00
0.00
D
Stock Option
4.36
2017-03-31
4
M
false
20000.00
0.00
D
2013-10-24
2022-10-24
Common Stock
20000.00
0.00
D
The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
The option vested in 2 equal annual installments beginning on April 25, 2013.
John Moore, attorney-in-fact for Reporting Person
2017-04-03